In addition to an increase in DNL enzyme expression, patients with MASLD also exhibited altered expression of FA binding protein (FABP), FA transport protein (FATP) [16,17,21,27,28], and CD36 [16,21,28]—genes responsible for FA uptake. This evidence concerns the gene DNASE2 and metabolic dysfunction-associated steatotic liver disease.